Quality appraisal of primary studies
Quantitative studies | Item number checklist | ||||||||||||||||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | |
Befort et al 81 | 2 | 2 | 1 | 0 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 1 | 1 | N/A | N/A | 1 |
Sleight et al 27 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 1 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Autade and Chauhan28 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 1 | N/A | 1 | 1 | 0 | 1 | N/A | N/A | 1 |
Chae et al 20 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 2 | 2 | 2 | 2 | N/A | N/A | 2 |
Cheng et al 6 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 0 | N/A | N/A | 2 |
Lee et al 32 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 2 | 2 | 2 | 1 | N/A | N/A | 2 |
Pauwels et al 30 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Vuksanovic et al 21 | 2 | 1 | 2 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Fong and Cheah12 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 1 | 2 | N/A | N/A | 2 |
Chou et al 34 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Cheng et al 10 | 2 | 2 | 2 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 2 | 2 | 2 | 1 | N/A | N/A | 2 |
Ellegaard et al 37 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Brennan et al 41 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 0 | 2 | 2 | 1 | N/A | N/A | 2 |
Bu et al 42 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 2 | N/A | N/A | 2 |
Fang et al 46 | 2 | 2 | 2 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 0 | 2 | 2 | 2 | N/A | N/A | 2 |
So et al 45 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 0 | 2 | 2 | 2 | N/A | N/A | 2 |
Miyashita et al 52 | 2 | 2 | 2 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 1 | 2 | 2 | 1 | N/A | N/A | 2 |
Hodgkinson et al 47 | 2 | 2 | 1 | 1 | N/A | N/A | N/A | N/A | 2 | N/A | 0 | 2 | 2 | 2 | N/A | N/A | 2 |
Martinez Arroyo et al 48 | 2 | 2 | 1 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 0 | 2 | 2 | 1 | N/A | N/A | 2 |
Park and Hwang54 | 2 | 2 | 2 | 2 | N/A | N/A | N/A | N/A | 2 | N/A | 2 | 2 | 2 | 2 | N/A | N/A | 2 |
Item number checklist key: (1) hypothesis/aim/objective clearly described, (2) study design well described and appropriate, (3) method of patient/control group selection clearly described, (4) characteristics of the patient/control group clearly described, (5) patients randomised to the intervention group, (6) randomisation/allocation concealed, (7) characteristics of patients lost to follow-up clearly described, (8) intervention clearly described, (9) main outcome measures clearly described, (10) attempt made to blind those measuring the primary outcome of the intervention, (11) population characteristics adequately described and controlled, (12) main findings clearly described, (13) methods of analysis appropriately and clearly described, (14) estimates of variance reported for main results, (15) analyses adjusted for different lengths of follow-up, (16) data analysed according to intention-to-treat principle, (17) conclusions supported by the results. Three levels of quality assessment of scores: ▢ low risk of bias (2), ▢ unclear risk of bias (1), ▢ high risk of bias (0).